Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
13%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
THNR
20
HOLDINGS
15%
ALSO IN IDNA
IDNA
44
HOLDINGS
8%
ALSO IN THNR
SECTOR DRIFT (THNR minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in THNR |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
REGENERON PHARMACEUTICALS | 7.8% | 4.6% | 4.6% | |
MERCK & CO. INC. | 5.5% | 4.3% | 4.3% | |
ROCHE HOLDING LTD | 5.0% | 3.9% | 3.9% |
THNR Overweight Relative to IDNA
ELI LILLY & CO | 11.4% | |
NOVO-NORDISK A/S-SPONS ADR | 9.1% | |
AMGEN INC | 6.8% | |
ABBVIE INC | 5.7% | |
CHUGAI PHARMACEUTICAL CO LTD | 5.6% | |
ASTRAZENECA PLC-SPONS ADR | 5.6% | |
PFIZER INC | 5.4% | |
GILEAD SCIENCES INC | 5.3% | |
INNOVENT BIOLOGICS, INC. | 5.2% | |
CHINA PHARMACEUTICAL GROUP | 4.9% |
THNR Underweight Relative to IDNA
INCYTE CORP | -4.8% | |
GENMAB A/S | -4.3% | |
ASTRAZENECA PLC | -4.3% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.1% | |
ARCELLX, INC. | -4.1% | |
BIONTECH SE SPONSORED ADR | -4.0% | |
SANOFI-AVENTIS | -4.0% | |
MODERNA, INC. | -3.8% | |
GSK PLC | -3.8% | |
CELCUITY INC. | -3.5% |